Patents are necessary to incentivise research into this vital area of medicine, write Philip Stevens and Jack Ellis
Combining different drugs into a single pill can have enormous therapeutic benefits but research and development is difficult and costly, write Philip Stevens and Jack Ellis
Improving access to innovative medicines will deliver social and economic benefits, writes Philip Stevens.
Global IP rules need a refresh to take account of rapidly changing technology, write Philip Stevens and Nigel Cory.
The European Commission is undermining innovation on the continent through its contradictory policy making around innovation.
This paper examines the reasons for farmer suicides in India, which stem from government interventions that result in agricultural market failures on a wide scale.
Egypt is about to slash the waiting time for drug approvals by 90%, in a move that will benefit patients and save lives, write Jasson Urbach and Philip Stevens.
El país podría construir una bioeconomía si trabajara en reducir las barreras regulatorias. Por ejemplo, en promedio toma 225 días para que el gobierno apruebe una prueba clínica. En Singapur es menos de un mes.
The upgrading of India’s IP laws as a result of its WTO commitments has confounded sceptics by encouraging its generics companies to move towards innovation.